Axogen (AXGN) EPS (Basic) Growth (1y) (2011 - 2026)
Axogen (AXGN) EPS (Basic) Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -18.87% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 13.56% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 18.90% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 97.93% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 92.23% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 114.97% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -29.95% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Axogen | 2.05 Bn | 1.95 Bn | 46.19 Mn | 33.59% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33.59% |
| Dec 31, 2025 | -24,842.18% |
| Sep 30, 2025 | 123.39% |
| Jun 30, 2025 | 93.44% |
| Mar 31, 2025 | 47.21% |
| Dec 31, 2024 | 99.55% |
| Sep 30, 2024 | 64.61% |
| Jun 30, 2024 | 71.71% |
| Mar 31, 2024 | 22.01% |
| Dec 31, 2023 | -93.59% |
| Sep 30, 2023 | 12.11% |
| Jun 30, 2023 | 10.90% |
| Mar 31, 2023 | 34.88% |
| Dec 31, 2022 | 15.48% |
| Sep 30, 2022 | 26.33% |
| Jun 30, 2022 | -11.68% |
| Mar 31, 2022 | -84.36% |
| Dec 31, 2021 | 9.20% |
| Sep 30, 2021 | 35.99% |
| Jun 30, 2021 | 7.03% |